Article

IRIDEX launches two photocoagulator systems

IRIDEX Corp. launched a dual-port ophthalmic green laser photocoagulator (IQ 532) and a modular multi-wavelength laser photocoagulator at the recent annual meeting of the American Academy of Ophthalmology.

San Francisco

-IRIDEX Corp. launched a dual-port ophthalmic green laser photocoagulator (IQ 532) and a modular multi-wavelength laser photocoagulator at the recent annual meeting of the American Academy of Ophthalmology.

The green laser photocoagulator has two features designed to make the device convenient and quick to set up and operate, according to Theodore A. Boutacoff, IRIDEX president and chief executive officer. The dual-port laser output allows physicians to connect a delivery device to each laser port and then switch between devices without changing connections, he said. The user interface features a touchscreen with options for storing system presets, such as physician treatment settings and voice confirmation, Boutacoff added.

The multi-wavelength laser photocoagulator uses two wavelengths, yellow (577 nm) and infrared (810 nm), he said. Each module can be purchased as a separate, stand-alone laser and then, at any time, can be combined with the other module, using the company’s slit-lamp adapter (Symphony 2) to create a multi-wavelength system tailored to meet the customer’s specific needs, according to the company.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
© 2025 MJH Life Sciences

All rights reserved.